Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Dynamin 2 ELISA Kit (AC3223)
Cat.#: ASET-1812
Specifications
Description Human Dynamin 2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Dynamin 2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 5.33 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 75-1200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1489 Human PROX1 ELISA Kit (AC2900) Quantitative inquiry ASET-1344 Rat Dopamine Transporter ELISA Kit (AC2755) Quantitative inquiry ASET-1364 Rat Dio3 ELISA Kit (AC2775) Quantitative inquiry ASET-2228 Mouse Syndecan-1 ELISA Kit (AC3639) Quantitative inquiry ASET-2249 Mouse Pcsk1n ELISA Kit (AC3660) Quantitative inquiry ASET-2446 Human Tau ELISA Kit (AC3857) Quantitative inquiry ASET-2094 Mouse VMAT2 ELISA Kit (AC3505) Quantitative inquiry ASET-1415 Mouse nNOS (neuronal) ELISA Kit (AC2826) Quantitative inquiry ASET-1708 Porcine Galectin-3 ELISA Kit (AC3119) Quantitative inquiry ASET-1230 Mouse DLK-1 ELISA Kit (AC2641) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket